Fresenius appoints board member: stock pre-market at EUR 44.17
Published on 10/16/2026 at 07:51 | Editorial responsibility: Rafael MĂĽller, Editor-in-Chief AD HOC NEWSLeadership changes and trading outlook
- Fresenius will appoint Marc-Alexander Mahl to its Management Board effective November 1, 2026.
- Fresenius stock trades pre-market at EUR 44.17 at 7:49 a.m. CEST at Lang & Schwarz on October 16, 2026.
- Sara Hennicken’s contract as chief financial officer will run until 2032.
Fresenius announced on October 15, 2026, that its Supervisory Board had appointed Marc-Alexander Mahl to the Management Board effective November 1, 2026. The pre-market price was EUR 44.17 at Lang & Schwarz at 7:49 a.m. CEST on October 16, 2026. The bid was EUR 44.08 and the ask was EUR 44.27. The further course from the Xetra open at 9:00 a.m. CEST is shown by the continuously updated real-time quote of Fresenius stock.
Management Board appointments
According to the EQS News release, Mahl will succeed Pierluigi Antonelli and take responsibility for the Fresenius Kabi businesses. Mahl, 58, has led the Pharma and Nutrition businesses since May 2023.
The company also said Chief Financial Officer Sara Hennicken’s contract had been extended for another five years and will therefore run until 2032. Sébastien Guery will assume overall responsibility for the Nutrition business at Fresenius Kabi, while Mahl will continue to lead the Pharma business unit.
What matters today
The next substantiated leadership date is November 1, 2026, when Mahl is scheduled to join the Management Board. Mahl is 58 years old and has worked at Fresenius since July 2001, with a brief interruption. Hennicken’s extended contract provides a management horizon through 2032.
Market context: Market report DAX.
